Advocacy

ASRA Comments on Opioid Product and Policy Issues
Dec 6, 2017
Multisociety Pain Workgroup Issues Statement Repudiating Conclusions of MINT Trials
Nov 22, 2017
ASRA Comments on CMS’s 2018 Proposed Rule
Aug 21, 2017
ASRA Applauds Federal Pain Research Strategy
Jun 5, 2017
ASRA Urges CA Workers’ Comp Coverage of Spinal Cord Stimulation
Mar 13, 2017
Organizations Provide Guidance to Oregon Health Authority Regarding Epidural Steroid Injections
Dec 8, 2016
ASRA, CMS Meet to Discuss Quality Payment Program Proposed Rule
Oct 18, 2016
ASRA Submits Comments to CMS Regarding PILD
Oct 6, 2016
Societies Provide Comments to FDA Regarding Opioid Use in Children
Aug 30, 2016
ASRA Seeks Feedback on Performance Measures for CMS
Aug 23, 2016
ASRA Comments on CMS's Patient Relationship Categories and Codes
Aug 15, 2016
ASRA Joins Forces on Ambulatory Infection Prevention Project
Aug 12, 2016
ASRA Provides Formal Comments on MIPS and APM
Jun 27, 2016
ASRA Urges Reconsideration of High Frequency Spinal Cord Stimulation Coverage Denial
Jun 17, 2016
ASRA Seeks Input on MACRA
May 31, 2016
ESI Coverage Now Threatened in Oregon
May 19, 2016
ASRA Provides Comments to FDA Regarding Opioid Analgesics REMS
Apr 27, 2016
ASRA Provides Written Testimony to FDA Regarding Opioid Prescribing Recommendations
Feb 23, 2016
MPW Provides Feedback on Washington State Health Care Authority Review of Spinal Injections
Sep 16, 2015
Multisociety Pain Workgroup Raises Serious Concerns About AHRQ Report
Aug 3, 2015